Investing In Psychoactives

“Neurons to Nirvana,” a superb documentary directed by Oliver Hockenhull, provides context for a piece of mail that arrived today, a stock advisory. The headline is “Investors Guide to Emerging Marijuana Markets.”   A company is touting “advanced development of medical marijuana-based cancer treatments.”

As the flier points out, marijuana is now accepted for medicinal use in over half the states. “The U.S. marijuana market is taking shape to become one of the biggest money-making opportunities in your lifetime.”

What? Only a lifetime ago the classic scare flick, “Reefer Madness,” was solemnly warning that smoking pot could lead to addiction, madness, and death. This attitude produced the war on drugs: billions spent, many people incarcerated, scientific researchers impeded. Meanwhile, millions of underground users have not been assured of purity and drug cartels have got rich.

But something appears to be changing.

 That change has many progenitors. One is Rick Doblin, a graduate of the Kennedy School at Harvard and founder of the Multidisciplinary Association for Psychedelic Studies or MAPS. He is among the experts who appear in “Neurons to Nirvana.”

To read more, visit

Posted in: Investing

Comments are closed.